Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;92(9):808-11.
doi: 10.1136/adc.2006.105692.

The EU's new paediatric medicines legislation: serving children's needs?

Affiliations
Review

The EU's new paediatric medicines legislation: serving children's needs?

Govin Permanand et al. Arch Dis Child. 2007 Sep.

Abstract

In new legislation for paediatric medicines which came into effect on 26 January 2007, the European Union (EU) has attempted to address several unresolved issues relating to children's needs for medicines in Europe. This article reviews the legislation's main proposals and makes some comparisons with equivalent legislation in the USA. We argue that the legislation suffers from several gaps and uncertainties in relation to the specific proposals and their intended aims. As the establishment of new legislation in this area offered the EU an opportunity to set some clear guidelines and objectives, and had the potential to go beyond the equivalent American rules, we thus see the proposals as something of a disappointment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

Cited by

References

    1. 't Jong G W, Eland I A, Sturkenboom M C.et al Unlicensed and off‐label prescription of respiratory drugs to children. Eur Respir J 200423310–313. - PubMed
    1. Pandolfini C, Impicciatore P, Provasi D.et al Off‐label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 200291339–347. - PubMed
    1. Standing J F, Tuleu C. Paediatric formulations‐‐getting to the heart of the problem. Int J Pharm 200530056–66. - PubMed
    1. Saint Raymond A, Brasseur D. Development of medicines for children in Europe: ethical implications. Paediatr Respir Rev 2005645–51. - PubMed
    1. Stephenson T. Medicines for children – the last century and the next. Arch Dis Child 200185177–179. - PMC - PubMed